Sign Out
Olanzapine do not appear to increase the risk of fetal teratogenicity. The rate of spontaneous abortions in pregnant women exposed to olanzapine was not found to be higher than that of the general population; however this drug increased the risk of hyperglycaemia in pregnant women.
The effect of olanzapine on breast-fed infants is unknown, its use by mothers during breast-feeding, may be of concern since antipsychotic drugs do appear in breast milk and this could conceivably alter CNS function in the infant both in the short and long term.
Continue with Google